Intelligence Β· Patent portfolio
First People's Hospital Patents
Full USPTO pharma patent portfolio for First People's Hospital β grant dates, expiration, and drug cross-links.
- Patents
- 123
- Expiring β€24m
- 0
Quick answer
First People's Hospital has 123 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β use filters for patent-cliff planning.
-
US 12357666
Traditional Chinese herbal plant composition for improving symptoms of liver cancer patients and compatibility method thereof
granted -
US 12228572
Enhanced expression of polo-like kinase 3 (PLK3) in human immunodeficiency virus (HIV)-infected cells
granted -
US 12220446
Use of upstream open reading frame 45aa-uORF nucleotide sequence of PTEN gene and polypeptide coded by 45aa-uORF
granted -
US 12090156
Application of CB-839 in preparation of drug for inhibiting corneal neovascularization (CNV)
granted -
US 12076443
Preparation method of nanozyme composite-based hybrid hydrogel eye drop
granted -
US 12016950
Devices and methods for treating ear pain
granted -
US 11992555
Solid solution compositions and use in chronic inflammation
granted -
US 11980602
Cannabinoid prodrug compounds
granted -
US 11918654
Solid solution compositions and use in severe pain
granted -
US 11844773
Solid solution compositions and use in chronic inflammation
granted -
US 11826325
Use of Belinostat or pharmaceutically acceptable salt thereof in preparation of drug for treating infection
granted -
US 11826428
Solid solution compositions comprising cannabidiols
granted -
US 11793777
Methods and compositions for treating conditions associated with an abnormal inflammatory response
granted -
US 11761003
Adeno-associated virus for activating RNA-NEAT1 over-expression and applications thereof
granted -
US 11744812
Methods of treatment
granted -
US 11730709
Compositions and methods for treating severe pain
granted -
US 11712427
Method for increasing serum adiponectin for treatment and reduction of the risk of cardiovascular, vascular, and related diseases
granted -
US 11712461
Long-acting polypeptide composition for treating atrial fibrillation and its application
granted -
US 11666596
Nucleotide, polypeptide and applications thereof
granted -
US 11660276
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 11633361
Soft chew pharmaceutical formulations
granted -
US 11583489
Flushable wipe and method of forming the same
granted -
US 11564896
Methods of treatment
granted -
US 11524044
Strengthening and tumor eliminating traditional Chinese medicine composition, its preparation method and application
granted -
US 11369657
Small molecule polypeptide for preventing and restraining inflammation and application of same
granted -
US 11332540
Use of Circ-CDH1 inhibitors
granted -
US 11224659
Solid solution compositions and use in severe pain
granted -
US 11202831
Solid solution compositions and use in cardiovascular disease
granted -
US 11154500
Solid solution compositions and use in chronic inflammation
granted -
US 11124901
Composite fabric, method for forming composite fabric, and use of a composite matter fabric
granted -
US 11103472
Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)
granted -
US 11065218
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 11065199
Devices and methods for treating ear pain
granted -
US 11000493
Solid solution compositions and use in chronic inflammation
granted -
US 10993843
Head trauma bandage cap and method
granted -
US 10980756
Methods of treatment
granted -
US 10912746
Methods and compositions for treating conditions associated with an abnormal inflammatory response
granted -
US 10905666
Methods and compositions for treating conditions associated with an abnormal inflammatory response
granted -
US 10874635
Tocotrienol compositions
granted -
US 10857114
Compositions and methods for treating severe pain
granted -
US 10849869
Compositions and methods for treating chronic inflammation and inflammatory diseases
granted -
US 10849867
Methods and compositions for treating conditions associated with an abnormal inflammatory response
granted -
US 10835490
Solid solution compositions and use in chronic inflammation
granted -
US 10799468
Methods and compositions for treating conditions associated with an abnormal inflammatory responses
granted -
US 10772854
Methods and compositions for treating conditions associated with an abnormal inflammatory response
granted -
US 10744152
Application of Asarum total polysaccharides in preparation of medicine for treating cough
granted -
US 10744103
Methods and compositions for treating conditions associated with an abnormal inflammatory responses
granted -
US 10695431
Solid solution compositions and use in cardiovascular disease
granted
Frequently asked questions
How many patents does First People's Hospital have?
123 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do First People's Hospital patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory